当前位置:首页 - 行情中心 - 达安基因(002030) - 财务分析 - 现金流量表

达安基因

(002030)

  

流通市值:93.19亿  总市值:93.19亿
流通股本:14.03亿   总股本:14.03亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金209,327,655.561,237,264,874.67813,245,333.21486,896,849.46
  收到的税费返还150,359.32644,902.39490,522.75284,910.99
  收到其他与经营活动有关的现金103,371,358.66663,271,502.58522,791,928.21358,999,397.28
  经营活动现金流入小计312,849,373.541,901,181,279.641,336,527,784.17846,181,157.73
  购买商品、接受劳务支付的现金88,984,150.74461,754,432.73326,708,733.98206,122,856.99
  支付给职工以及为职工支付的现金128,099,894.38363,597,158.34344,383,640.66245,673,189.9
  支付的各项税费6,468,338.3529,802,684.7431,500,976.5321,940,344.85
  支付其他与经营活动有关的现金134,930,638.11726,537,750.47552,416,531.45383,087,370.51
  经营活动现金流出小计358,483,021.581,581,692,026.281,255,009,882.62856,823,762.25
  经营活动产生的现金流量净额-45,633,648.04319,489,253.3681,517,901.55-10,642,604.52
二、投资活动产生的现金流量:
  收回投资收到的现金269,082,0001,095,884,805.06604,883,045.68239,883,045.68
  取得投资收益收到的现金2,128,399.0429,676,851.622,519,379.782,878,071.05
  处置固定资产、无形资产和其他长期资产收回的现金净额0424,655.96244,973.65245,347.38
  收到的其他与投资活动有关的现金38,412,500732,791,710.66632,790,000600,000,000
  投资活动现金流入小计309,622,899.041,858,778,023.281,260,437,399.11843,006,464.11
  购建固定资产、无形资产和其他长期资产支付的现金8,798,807.78238,999,279.14172,105,488.81116,290,768.42
  投资支付的现金263,560,0001,632,290,379.04930,513,379.04569,513,379.04
  支付其他与投资活动有关的现金0624,806,188.61574,806,188.61500,000,000
  投资活动现金流出小计272,358,807.782,496,095,846.791,677,425,056.461,185,804,147.46
  投资活动产生的现金流量净额37,264,091.26-637,317,823.51-416,987,657.35-342,797,683.35
三、筹资活动产生的现金流量:
  吸收投资收到的现金500,000000
  其中:子公司吸收少数股东投资收到的现金500,000000
  取得借款收到的现金48,979,000123,008,582.2882,511,520.0943,360,867.5
  收到其他与筹资活动有关的现金04,902,171.3314,900,0009,900,000
  筹资活动现金流入小计49,479,000127,910,753.6197,411,520.0953,260,867.5
  偿还债务支付的现金32,017,056.5158,049,036133,889,726103,633,326
  分配股利、利润或偿付利息支付的现金1,185,655.368,457,272.672,828,231.182,042,491.43
  支付其他与筹资活动有关的现金360,718.795,958,076.351,002,486.86743,531.38
  筹资活动现金流出小计33,563,430.65172,464,385.02137,720,444.04106,419,348.81
  筹资活动产生的现金流量净额15,915,569.35-44,553,631.41-40,308,923.95-53,158,481.31
四、汇率变动对现金及现金等价物的影响-720,604.91-1,331,249.4-887,822.91-429,638.66
五、现金及现金等价物净增加额6,825,407.66-363,713,450.96-376,666,502.66-407,028,407.84
  加:期初现金及现金等价物余额503,658,427.3867,371,878.26867,371,878.26867,371,878.26
  期末现金及现金等价物余额510,483,834.96503,658,427.3490,705,375.6460,343,470.42
补充资料:
  净利润--780,521,960.65--190,124,632.54
  资产减值准备-436,991,981.1-5,828,434.13
  固定资产和投资性房地产折旧-148,169,554.51-92,464,575.59
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-148,169,554.51-92,464,575.59
  无形资产摊销-142,837,743.93-69,142,480.83
  长期待摊费用摊销-20,199,265.52-5,619,533.75
  处置固定资产、无形资产和其他长期资产的损失--5,476,467.27--476,575.74
  固定资产报废损失-5,351,082.78-4,075,401.17
  公允价值变动损失--4,572,082.42--85,568,280.89
  财务费用-4,185,770.56-2,100,374.22
  投资损失--49,428,681.35--4,777,877.08
  递延所得税-16,677,417.29--33,697,862.43
  其中:递延所得税资产减少-14,036,475.42--47,072,964.16
    递延所得税负债增加-2,640,941.87-13,375,101.73
  存货的减少-41,271,030.36-11,169,125.98
  经营性应收项目的减少-398,866,558.38-133,877,198.72
  经营性应付项目的增加--178,571,032.01--193,221,927.97
  其他-0-0
  债务转为资本-0-0
  一年内到期的可转换公司债券-0-0
  融资租入固定资产-0-0
  不涉及现金收支的投资和筹资活动金额其他项目-4,436,208.16--
  现金的期末余额-503,658,427.3-460,343,470.42
  减:现金的期初余额-867,371,878.26-867,371,878.26
  加:现金等价物的期末余额-0-0
  减:现金等价物的期初余额-0-0
  现金及现金等价物的净增加额--363,713,450.96--407,028,407.84
公告日期2026-04-282026-04-282025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑